A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with Tourette syndrome will be conducted by Wesley Medical Research, with the cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney.

The trial is the first of its kind in Australia and will take place at Wesley Medical Research in Brisbane led by Chief Investigator and neuropsychiatrist Dr Philip Mosley.

Participants will complete two periods of treatment with either a medicinal cannabis drug or a placebo, with both investigators and participants unaware of treatment status until the end of the trial.

Click here to read the complete article

University of Sydney

Recent News Articles

Monday July 22

How can Texas fix its marijuana problem after legalizing hemp? Forensic experts have a plan…

in Law & Crime

by Bruce Kennedy - Editor in Chief

Prosecutors and crime lab scientists were scrambling to find a solution after a change in…

275 hits

Monday July 22

Medical pot is helping Minnesotans with PTSD - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Minnesotans who use medical pot to treat post-traumatic stress disorder are reporting less anxiety and…

354 hits

Monday July 22

Marijuana tourism lifts off in east Oregon - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

“There is a piece of touring that does belong to marijuana."

231 hits

Monday July 22

Cannabis industry gets crafty with terpenes - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

Terpenes, terpenoids, terps. Whatever you call them, these compounds in cannabis that give it distinctive…

240 hits

Tuesday July 23

Top Congressional Chairman And Presidential Candidate File Marijuana Legalization Bills - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

The chairman of a key congressional committee responsible for crime policy is teaming up with…

217 hits